CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH CIRRHOSIS DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN SWEDEN

被引：0
|
作者：
Shang, Ying [1 ]
Zhang, Xiao [2 ]
Fernandes, Gail [2 ]
Melaragno, Matthew [2 ]
Engel, Samuel [2 ]
Vessby, Johan [3 ]
Ekstedt, Mattias [4 ]
Hagstrom, Hannes [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Merck & Co Inc, Rahway, NJ USA
[3] Uppsala Univ Hosp, Uppsala, Sweden
[4] Linkoping Univ, Linkoping, Sweden
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1085
引用
收藏
页码：S821 / S822
页数：2
相关论文
共 50 条
  • [31] Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Zazueta, Alejandra
    Valenzuela-Perez, Lucia
    Ortiz-Lopez, Nicolas
    Pinto-Leon, Araceli
    Torres, Veronica
    Guinez, Danette
    Aliaga, Nicolas
    Merino, Pablo
    Sandoval, Alexandra
    Covarrubias, Natalia
    Perez de Arce, Edith
    Cattaneo, Maximo
    Urzua, Alvaro
    Roblero, Juan Pablo
    Poniachik, Jaime
    Gotteland, Martin
    Magne, Fabien
    Beltran, Caroll Jenny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [32] PROGNOSTIC SIGNIFICANCE OF ELF TEST COMPARED TO LIVER BIOPSY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Galletti, Simone
    Cardinali, Sara
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Rapaccini, Gian Ludovico
    Pompili, Maurizio
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    HEPATOLOGY, 2024, 80 : S662 - S662
  • [33] Prognostic significance of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Beschi, Riccardo
    Orienti, Marco
    Cardinali, Sara
    Galletti, Simone
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Ainora, Maria Elena
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Vecchio, Fabio Maria
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    JOURNAL OF HEPATOLOGY, 2024, 80 : S533 - S533
  • [34] METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - HOW COMMON IS IT?
    Scheetz, Kate
    Kalagara, Sanah
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    Vuppalanchi, Raj
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S478
  • [35] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [36] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Shin, Soyeon
    Kim, Jaeyoung
    Lee, Ju Yeon
    Kim, Jun
    Oh, Chang-Myung
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
  • [37] Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
    Hutchison, Alan L.
    Tavaglione, Federica
    Romeo, Stefano
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1524 - 1541
  • [38] USEFULNESS OF SERUM MICRORNAS AS BIOMARKERS FOR PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Blakley, Caroline
    Nelson, Benjamin
    Qarooni, Shatha
    Lee, Wai Han
    Tryggestad, Jeanie
    Short, Kevin
    Palle, Sirish Kumar
    HEPATOLOGY, 2024, 80 : S626 - S626
  • [39] HEALTHCARE PROVIDERS' PERSPECTIVES ON NEW METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) NOMENCLATURE
    Albhaisi, Somaya
    Albhaisi, Omar
    HEPATOLOGY, 2024, 80 : S890 - S891
  • [40] Prognostic role of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Viceconti, N.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Garcovich, M.
    Pizzolante, F.
    De Matthaeis, N.
    Zocco, M. A.
    Ainora, M. E.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S12 - S12
12345